We are live on ! Find out more
STLN

Starling Oncology
STLN

6.96 USD
+0.33
4.98%
At close Updated Sep 18, 4:00 PM EDT
Pre-market
After hours
6.83
-0.13
1.87%
1 day
4.98%
5 days
12.99%
1 month
8.75%
3 months
32.32%
6 months
93.33%
Year to date
89.65%
1 year
114.81%
5 years
-29.77%
10 years
-28.25%
 

About: Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.

Employees: 641

Healthcare Medical Care Facilities

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 25%
Neutral 66.7%
Negative 8.3%
Neutral
GlobeNewsWire
27 days ago
Starling Oncology to Participate in Wells Fargo Healthcare Conference
CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Wells Fargo Healthcare Conference, being held in Boston on Tuesday, September 8, 2026, including a fireside chat from 4:30–5:05 p.m.
Starling Oncology to Participate in Wells Fargo Healthcare Conference
Neutral
GlobeNewsWire
1 month ago
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced the launch of Starling Oncology Nexus, a proprietary technology platform built to address one of cancer care's persistent challenges: NCCN compliance by the medical community and a fragmented and administratively burdensome prior authorization process for providers.
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
Neutral
Seeking Alpha
1 month ago
Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript
Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript
Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
The Oncology Institute, Inc. (STLN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.14 per share a year ago.
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it's full-year 2026 guidance.
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Neutral
GlobeNewsWire
1 month ago
The Oncology Institute Rebrands as Starling Oncology
CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or “the Company”), one of the largest value-based oncology groups in the United States, announced today that it has rebranded to “Starling Oncology, Inc.™.
The Oncology Institute Rebrands as Starling Oncology
Neutral
GlobeNewsWire
1 month ago
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its second quarter 2026 financial results on Thursday, August 6, 2026, to be followed by a conference call the same day at 5:00 p.m.
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Positive
Zacks Investment Research
2 months ago
Best Cheap Stocks Under $10 to Buy Now in July
One area of Wall Street that investors might want to start buying are strong, best-in-class, cheap stocks trading under $10 a share in July and throughout the rest of 2026.
Best Cheap Stocks Under $10 to Buy Now in July
Neutral
GlobeNewsWire
2 months ago
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
CERRITOS, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, announced today that it has repaid its $86 Million senior secured convertible note with Deerfield Partners through a debt refinancing that includes new credit facilities from OrbiMed.
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
Positive
InvestorPlace
2 months ago
2 More Stocks to Buy for the AI Convergence
Tom Yeung here with your Sunday Digest . In the days following its IPO, Space Exploration Technologies Corp. ( SPCX ) surged 25%, rewarding early investors and turning its owner, Elon Musk, into a trillionaire.
2 More Stocks to Buy for the AI Convergence
See News Rankings
Price charts implemented using Lightweight Charts™